Showing results (371-380 of 888) with videos related to
Sort By:
Pageof 89
Scandinavian Journal of Immunology|January 9, 2024
IL-6 is associated with expansion of myeloid-derived suppressor cells and enhanced immunosuppression in pancreatic adenocarcinoma patientsVinit Sharma, Naresh Sachdeva, Vikas Gupta, et al.Critical Care Medicine|July 23, 2009
Burden of early-onset candidemia: analysis of culture-positive bloodstream infections from a large U.S. databaseAndrew F Shorr, Vikas Gupta, Xiaowu Sun, et al.Annals of Hepatology|December 17, 2009
Spontaneous rupture of hepatic metastasis from choriocarcinoma: a review of imaging and managementAjay Gulati, Sameer Vyas, Anupam Lal, et al.Bioinformation|September 22, 2025
in vitro evaluation of force required to luxate a newly loaded dental implant in bonePaulami Bagchi, Savita Hadakar, Ruchi Agrawal, et al.Journal of Family Medicine and Primary Care|October 28, 2020
Undernutrition and associated factors among children 1-5 years of age in rural area of Haryana, India: A community based cross-sectional studySuraj Chawla, Vikas Gupta, Abhishek Singh, et al.Annals of Biomedical Engineering|October 27, 2018
Impact of Pulmonary Venous Inflow on Cardiac Flow Simulations: Comparison with In Vivo 4D Flow MRIJonas Lantz, Vikas Gupta, Lilian Henriksson, et al.BMC Infectious Diseases|August 9, 2024
Outcomes of inadequate empiric therapy and timing of newer antibacterial therapy in hospitalized adults with culture-positive Enterobacterales and Pseudomonas aeruginosa: a multicenter analysisTodd Riccobene, Gang Ye, John Lock, et al.Cureus|February 12, 2024
Malignancy of Nose and Paranasal Sinuses: An Institutional Study in Central IndiaAnjan K Sahoo, Rohini R Nair, Utkal P Mishra, et al.Microbiology Spectrum|November 8, 2023
Real-world in vitro activity of newer antibiotics against Enterobacterales and Pseudomonas aeruginosa, including carbapenem-non-susceptible and multidrug-resistant isolates: a multicenter analysisTodd Riccobene, ChinEn Ai, Kalvin C Yu, et al.Cancers|June 22, 2023
Benefit of Early Ruxolitinib Initiation Regardless of Fibrosis Grade in Patients with Primary Myelofibrosis: A Post Hoc Analysis of the Single-Arm Phase 3b JUMP StudyFrancesca Palandri, Haifa Kathrin Al-Ali, Paola Guglielmelli, et al.Pageof 89